MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    An Internet of Things system for patient empowerment: a case study on measuring patients’ understanding of causal relationships between symptoms and behaviour

    L. Karni, M. Memedi, E. Kolkowska, I. Scandurra, P. de Roos, DA. Nyholm, G. Klein (Örebro, Sweden)

    Objective: To evaluate the ability of patients to understand causal relationships between disease symptoms and behaviour presented from synthetic representative cases using the system. Secondary…
  • 2019 International Congress

    Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS) based on Duration of Parkinson’s Disease and Dyskinesia

    X. Ren, J. Lin, S. Luo, C. Goetz, G. Stebbins, E. Cubo (Burgos, Spain)

    Objective: To assess differential item functioning (DIF) in the Unified Dyskinesia Rating Scale (UDysRS) to determine if the duration of Parkinson’s Disease (PD) and/or duration…
  • 2019 International Congress

    Validation of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease

    J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To assess the psychometric properties of the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s disease (PD) across levels of cognitive abilities.…
  • 2019 International Congress

    Association between the side of onset and the motor and non-motor symptoms in Parkinson’s Disease

    J. Silva, R. Guimarães, A. D'Abreu (Campinas, Brazil)

    Objective: Study the relation between the side of onset of the motor symptoms in Parkinson's Disease(PD) and motor and non-motor symptoms considering the dominant hand.…
  • 2019 International Congress

    Validation of the Hebrew version of the Unified Dyskinesia Rating Scale (UDysRS)

    A. Socher, A. Thaler, H. Shabtai, J. Zitser, T. Shainer, M. Kestenbaum, A. Rosenberg, A. Bar David, A. Ezra, T. Taichman, M. Brozgol, T. Herman, G. Stebbins, C. Goetz, S. Luo, P. Martinez-Martin, N. Giladi, T. Gurevich (Mdrid, Spain)

    Objective: To assess the clinimetric properties of the Hebrew version of the UDysRS. Background: Dyskinesia is a common side effect of dopaminergic treatments for Parkinson's…
  • 2019 International Congress

    Development and Validation of the Parkinson’s Disease Medication Adherence Scale (PD- MAS)

    M. Tosin, B. Oliveira (Niterói, Brazil)

    Objective: To develop and validate the PD-MAS. Background: Parkinson's disease (PD) is a neurodegenerative disease manifested by motor and non-motor symptoms, controlled with drug, neurosurgical…
  • 2019 International Congress

    “Best practice” guidelines for the collection and analysis of speech data in patients with Parkinson’s Disease (PD).

    E. Tripoliti, L. Ramig (Boulder Colorado, CO, USA)

    Objective: To discuss the literature for collection and analysis of speech data for patients with PD in order to create “best practice” guidelines. Background: Speech…
  • 2019 International Congress

    “UPDRS-meter” – a digital and automatic UPDRS scoring application

    Z. Yekutieli, S. Baer-Hassin, V. Livneh, T. Fay-Karmon, S. Israeli-Korn, G. Yahalom (Zichron Yaakov, Israel)

    Objective: To assess the feasibility of a smartphone-based application for performing a motor test that will provide an accurate UPDRS score. Background: Parkinson’s Disease (PD)…
  • 2019 International Congress

    A cortical signature of motor response to dopaminergic therapy in Parkinson’s disease

    J. Baarbé, K. Lizarraga, J. Saravanamuttu, U. Saha, R. Chen (Toronto, ON, Canada)

    Objective: To investigate whether cortical oscillations involved in sensorimotor processes might predict motor symptom response to dopaminergic treatment (MSRD) in Parkinson’s disease (PD). Background: MSRD…
  • 2019 International Congress

    A novel intermittent control paradigm to investigate oscillatory neuronal activity in the STN

    M. Boca, N. Ray, C. Kobylecki, J. Evans, I. Loram, M. Silverdale (Manchester, United Kingdom)

    Objective: To present a new methodology of recording STN local field potential (LFP) activity. Background: Recordings of LFPs from the subthalamic nucleus (STN) of patients…
  • « Previous Page
  • 1
  • …
  • 1103
  • 1104
  • 1105
  • 1106
  • 1107
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley